0001484612-21-000067.txt : 20211004
0001484612-21-000067.hdr.sgml : 20211004
20211004161714
ACCESSION NUMBER: 0001484612-21-000067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211001
FILED AS OF DATE: 20211004
DATE AS OF CHANGE: 20211004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trigg Leslie
CENTRAL INDEX KEY: 0001304125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 211302948
MAIL ADDRESS:
STREET 1: C/O OUTSET MEDICAL
STREET 2: 1830 BERING ROAD
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-10-01
0
0001484612
Outset Medical, Inc.
OM
0001304125
Trigg Leslie
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
1
1
0
0
Chief Executive Officer
Common Stock
2021-10-01
4
M
0
20000
2.93
A
270567
D
Common Stock
2021-10-01
4
S
0
20000
48.6929
D
250567
D
Common Stock
2021-10-01
4
M
0
12500
2.93
A
263067
D
Common Stock
2021-10-01
4
S
0
12500
48.7076
D
250567
D
Common Stock
2021-10-01
4
M
0
10000
2.93
A
260567
D
Common Stock
2021-10-01
4
S
0
10000
48.6878
D
250567
D
Common Stock
8770
I
Trigg Family Trust
Non-Qualified Stock Option (right to buy)
2.93
2021-10-01
4
M
0
20000
0.0
D
2025-07-22
Common Stock
20000
71873
D
Non-Qualified Stock Option (right to buy)
2.93
2021-10-01
4
M
0
12500
0.0
D
2025-07-22
Common Stock
12500
59373
D
Non-Qualified Stock Option (right to buy)
2.93
2021-10-01
4
M
0
10000
0.0
D
2025-07-22
Common Stock
10000
49373
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.77 to $49.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option vested in 48 equal monthly installments beginning on August 22, 2015.
By: Nabeel Ahmed For: Leslie Trigg
2021-10-04